|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.31 USD | +1.55% |
|
-12.08% | +122.03% |
| 21/05 | DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis | CI |
| 21/05 | Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon | MT |
DURECT Corporation announced that Jay Shepard will join its Board of Directors effective September 26, 2013. Separately, Michael Casey has made the decision to retire from the Board of Directors effective December 31, 2013. Shepard has over 30 years experience in the pharmaceutical, biotechnology and drug delivery fields.
Shepard currently serves as an Executive Partner at Sofinnova Ventures.
| 1st Jan change | Capi. | |
|---|---|---|
| +122.03% | 40.04M | |
| +15.82% | 121B | |
| +20.35% | 113B | |
| +17.47% | 26.02B | |
| -25.31% | 19.39B | |
| -19.51% | 15.91B | |
| -19.67% | 15.09B | |
| -46.87% | 15.06B | |
| +62.55% | 14.93B | |
| +6.34% | 13.85B |
DURECT CORPORATION 
